Last reviewed · How we verify
UCMSCs
At a glance
| Generic name | UCMSCs |
|---|---|
| Also known as | Human Umbilical Cord Derived Mesenchymal |
| Sponsor | Joshua M Hare |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Stem Cell and Conditioned Medium for Cerebral Palsy (PHASE1, PHASE2)
- UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX) (PHASE2, PHASE3)
- UCMSCs as Front-line Approach of Treatment for Patients With aGVHD (PHASE1, PHASE2)
- National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF) (PHASE1)
- National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial (PHASE2)
- National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial (PHASE3)
- Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study (PHASE1, PHASE2)
- UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- UCMSCs CI brief — competitive landscape report
- UCMSCs updates RSS · CI watch RSS
- Joshua M Hare portfolio CI